Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study.

Authors :: Varettoni M
Zibellini S
Merli M
Drandi D
Jiménez C
Furlan D
Ferretti VV
Fabbri N
Dogliotti I
Varraso C
Ferrante M
Cappello E
Peri V
Cavalloni C
Borriero M
Facchetti GV
Ferrero S
Arcaini L
Garcia-Sanz R
Source :: Hematological oncology [Hematol Oncol] 2023 Aug; Vol. 41 (3), pp. 574-577. Date of Electronic Publication: 2022 Oct 19.
Publication Year :: 2023

Subjects :: Humans
Progression-Free Survival
Mutation
Signal Transduction
Waldenstrom Macroglobulinemia drug therapy

Full Text Access

Tools